Effect of Lipopolysaccharide on the Xenobiotic-Induced Expression and Activity of Hepatic Cytochrome P450 in Mice

被引:39
|
作者
Moriya, Nozomu [1 ]
Kataoka, Hiromi [2 ]
Fujino, Hideki [1 ]
Nishikawa, Jun-ichi [2 ]
Kugawa, Fumihiko [1 ]
机构
[1] Hyogo Univ Hlth Sci, Dept Biopharmaceut, Chuo Ku, Kobe, Hyogo 6508530, Japan
[2] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Nishinomiya, Hyogo 6638179, Japan
关键词
cytochrome P450; induction; lipopolysaccharide; hepatic metabolism; inflammatory cytokine; transcriptional regulation; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; PREGNANE-X-RECEPTOR; CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; POLYCYCLIC AROMATIC-HYDROCARBONS; ENGINEERED C57BL/6J MICE; DRUG-METABOLISM; DOWN-REGULATION; NUCLEAR RECEPTORS; MOUSE-LIVER;
D O I
10.1248/bpb.35.473
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Infection-associated inflammation can alter the expression levels and functions of cytochrome P450s (CYPs). Cyp gene expression is regulated by the activation of several nuclear receptors, including pregnane X receptor (PXR), constitutive androstane receptor (CAR), and aryl hydrocarbon receptor (AhR). These receptors can be activated by xenobiotics, including medicines. Here, to study the xenobiotic-induced fluctuations in CYP during inflammation, we examined the effect of lipopolysaccharide (LPS) treatment on the level of mRNAs encoding hepatic CYPs induced by xenobiotic-activated nuclear receptors, in mice. Both the mRNA induction of Cyp genes and the metabolic activities of CYP proteins were examined. LPS treatment caused a significant decrease in the induced expression of the mRNAs for Cyp3a11, 2c29, 2c55, and 1a2, but not for Cyp2b10. To assess the CYP enzymatic activities, CYP3A-mediated testosterone 6 beta-hydroxylation and the intrinsic clearance (CLint) of nifedipine in liver microsomes were measured in mice treated with the xenobiotic pregnenolone-16alpha-carbonitrile (PCN) with or without LPS administration. Both assays revealed that the CYP3A activity, which was induced by PCN, declined significantly after LPS treatment, and this decline correlated with the Cyp3a11 mRNA level. In addition, we found that the mRNAs for interleukin (IL)-1 beta and tumor necrosis factor (TNF) alpha were increased after treatment with LPS plus xenobiotics. Our findings demonstrated that LPS treatment reduces the PXR- and AhR-mediated, and possibly CAR-mediated Cyp gene expression and further suggest that these decreases are dependent on inflammatory cytokines in the liver.
引用
收藏
页码:473 / 480
页数:8
相关论文
共 50 条
  • [31] Retention of xenobiotic-inducible cytochrome P450 gene expression in hepatocytes
    Price, PJ
    Samrock, RL
    LoboAlfonso, JO
    Green, CE
    IN VITRO TOXICOLOGY, 1997, 10 (03) : 365 - 371
  • [32] Mechanism-based inhibition of Alantolactone on human cytochrome P450 3A4 in vitro and activity of hepatic cytochrome P450 in mice
    Qin, Chong-Zhen
    Lv, Qiao-Li
    Wu, Na-Yiyuan
    Cheng, Lin
    Chu, Yun-Chen
    Chu, Tang-Yuan
    Hu, Lei
    Cheng, Yu
    Zhang, Xue
    Zhou, Hong-Hao
    JOURNAL OF ETHNOPHARMACOLOGY, 2015, 168 : 146 - 149
  • [33] INTERACTION OF BENZANTHRONE WITH CYTOCHROME P450 - ALTERED PATTERNS OF HEPATIC XENOBIOTIC METABOLISM IN RATS
    DAS, M
    GARG, K
    JOSHI, A
    SINGH, GB
    KHANNA, SK
    JOURNAL OF BIOCHEMICAL TOXICOLOGY, 1991, 6 (01): : 37 - 44
  • [34] Identification of human hepatic cytochrome P450 sources of N-alkylprotoporphyrin IX after interaction with porphyrinogenic xenobiotics, implications for detection of xenobiotic-induced porphyria in humans
    Lavigne, JA
    Nakatsu, K
    Marks, GS
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (07) : 788 - 794
  • [35] The Benzene-induced Hepatic Cytochrome P450 2E1 Expression and Activity are Reduced by Quercetin Administration in Mice
    Amir-Ata, Jamboor-Shabestary
    Mohammad-Reza, Vardast
    Malekinejad, Hassan
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (09) : 676 - 682
  • [36] Effects of Trolox on the activity and gene expression of cytochrome P450 in hepatic ischemia/reperfusion
    Eum, HA
    Lee, SM
    BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (01) : 35 - 42
  • [37] Regulation of cytochrome P450 gene expression and activity
    Maurel, P.
    Pascussi, J. M.
    Gerbal-Chaloin, S.
    Daujat, M.
    Vilarem, M. J.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 24 - 24
  • [38] Sex- and Species-differences on Xenobiotic-induced Toxicity: Differences in Constitutive and Xenobiotic-mediated Expression of Cytochrome P450 1A Subfamily Enzymes (CYP1As)
    Sekimoto, Masashi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (03): : 415 - 422
  • [39] Which P450: predicting which cytochrome p450 isoforms are involved in the metabolism of a xenobiotic
    Tyzack, Jon D.
    Foster, Nicholas W.
    Hunt, Peter
    Segall, Matthew D.
    DRUG METABOLISM REVIEWS, 2016, 48 : 45 - 45
  • [40] Which P450: Predicting which cytochrome P450 isoforms are involved in the metabolism of a xenobiotic
    Hunt, Peter
    Tyzak, Jonathan
    Segall, Matthew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251